118 related articles for article (PubMed ID: 16051333)
21. Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary.
Karaferic A; Jovanovic D; Jelic S
J BUON; 2009; 14(4):635-9. PubMed ID: 20148455
[TBL] [Abstract][Full Text] [Related]
22. Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers.
Buchynska LG; Iurchenko NP; Grinkevych VM; Nesina IP; Chekhun SV; Svintsitsky VS
Exp Oncol; 2009 Mar; 31(1):48-51. PubMed ID: 19300417
[TBL] [Abstract][Full Text] [Related]
23. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F; Steenkiste E; Schurmans K; Verbist L; Abeler VM; Tulunay G; de Jonge E; Massuger L; Moerman P; Vergote I
Int J Gynecol Cancer; 2004; 14(6):1118-21. PubMed ID: 15571618
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
Wang Y; Liu AJ; Chen X; Song X
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
[No Abstract] [Full Text] [Related]
26. Clinicopathological spectrum of 19 adenosarcomas of female genital tract, including uncommon clinical associations and immunohistochemical profile, reviewed at a single institution.
Rekhi B; Deodhar KK; Maheshwari A; Menon S; Kerkar R; Bajpai J; Ghosh J; Gupta S; Engineer R; Shrivastava SK
Indian J Pathol Microbiol; 2012; 55(3):326-32. PubMed ID: 23032825
[TBL] [Abstract][Full Text] [Related]
27. Ovarian adenosarcoma arising from benign cystadenoma and associated intraoperative consultation pitfalls.
Chen ZW; Saad RS
Int J Gynecol Pathol; 2010 Sep; 29(5):415-8. PubMed ID: 20736764
[TBL] [Abstract][Full Text] [Related]
28. [Ovarian cancer prognosis and expression of receptors to sex hormones and proliferative activity of tumor cells].
Novichkov EV; Votintsev AA
Arkh Patol; 2006; 68(2):10-3. PubMed ID: 16752501
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
30. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.
Reich O; Regauer S; Urdl W; Lahousen M; Winter R
Br J Cancer; 2000 Mar; 82(5):1030-4. PubMed ID: 10737385
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
[TBL] [Abstract][Full Text] [Related]
33. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
[TBL] [Abstract][Full Text] [Related]
34. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia.
Chiarelli S; Buriticá C; Litta P; Ciani S; Guarch R; Nogales FF
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4251-6. PubMed ID: 16857799
[TBL] [Abstract][Full Text] [Related]
35. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
Lee BH; Hecht JL; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
[TBL] [Abstract][Full Text] [Related]
36. Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.
Akahira J; Inoue T; Suzuki T; Ito K; Konno R; Sato S; Moriya T; Okamura K; Yajima A; Sasano H
Br J Cancer; 2000 Dec; 83(11):1488-94. PubMed ID: 11076658
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical localisation of aromatase and its correlation with progesterone receptors in ovarian epithelial tumours.
Kitawaki J; Noguchi T; Yamamoto T; Yokota K; Maeda K; Urabe M; Honjo H
Anticancer Res; 1996; 16(1):91-7. PubMed ID: 8615676
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
39. Primary vaginal adenosarcoma with sarcomatous overgrowth.
Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N
Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000
[TBL] [Abstract][Full Text] [Related]
40. Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases.
Hwang HC; Mills SE; Patterson K; Gown AM
Mod Pathol; 1998 Nov; 11(11):1122-6. PubMed ID: 9831211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
